Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
4don MSN
Kidney organoids uncover Hippo signaling pathway as a therapeutic target for nephronophthisis
Using human-induced pluripotent stem cell-derived kidney organoids, researchers from Science Tokyo uncovered how abnormal ...
In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses the screening process for chronic kidney disease.
Blocking fatty ceramides could stop acute kidney injury—and possibly revolutionize mitochondrial disease treatment.
Millions in India face chronic kidney disease, with drug-induced damage a significant concern. Common medications like NSAIDs ...
Choosing a 10th-grade stream is crucial; parental influence can derail dreams. Empowering students to select based on interest fosters engagement, responsibility, and reduces stress. Passionate ...
On October 7, 2025, Merck announced the completion of the Verona Pharma acquisition. Verona is now a wholly-owned subsidiary of Merck. Ohtuvayre, a first-in-class maintenance treatment for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback